Edna B. Foa

Edna B. Foa

Auto-generated profile, based on publicly available information

Edna B. Foa

Center for the Treatment and Study of Anxiety, Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Suite 601N, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in JAMA
Verified
Journal Article
Open access
PDF file
EFEdna B. Foa
Edna B. Foa
CMCarmen P. McLean
Carmen P. McLean
YZYinyin Zang
Yinyin Zang
DRDavid Rosenfield
David Rosenfield
EYElna Yadin
Elna Yadin
FCfor the STRONG STAR Consortium
for the STRONG STAR Consortium
Quiz Ref ID Posttraumatic stress disorder (PTSD) affects 10% to 20% of military personnel returning from deployments to Iraq and Afghanistan1-3 and is often chronic and debilitating.4,5 The psychological and physical toll of PTSD is substantial,6 highlighting the need to develop effective treatments. Prolonged exposure therapy for PTSD is a manualized, trauma-focused cognitive behavioral therapy that has empirical support in civilians7 and veterans.8,9 However, knowledge about the efficacy of prolonged exposure therapy among active duty military personnel is limited to case studies.10 One barrier to implementation of prolonged exposured therapy in the military is treatment length (8-15 weeks), which can conflict with military obligations. A shorter course of therapy could hasten amelioration of PTSD, with the added benefit of facilitating military readiness. Massed (daily) prolonged exposure therapy (massed therapy) has been demonstrated to be as effective as weekly sessions for treatment of agoraphobia,11 obsessive-compulsive disorder,12 and panic disorder.13,14 A randomized clinical trial (RCT) in civilians with PTSD found 1 week of daily cognitive therapy equivalent to 3 months of weekly sessions.15 Thus, massed therapy was expected to be noninferior to typical spaced prolonged exposure therapy (spaced therapy).

1 July 2019 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
DBDanielle S. Berke
Danielle S. Berke
NKNora K. Kline
Nora K. Kline
JWJennifer Schuster Wachen
Jennifer Schuster Wachen
CMCarmen P. McLean
Carmen P. McLean
JYJeffrey S. Yarvis
Jeffrey S. Yarvis
BLBrett T. Litz
Brett T. Litz

20 May 2022 in Behaviour Research and Therapy
Verified
Journal Article
Open access
SKShannon M. Kehle-Forbes
Shannon M. Kehle-Forbes
PAPrincess E. Ackland
Princess E. Ackland
MSMichele R. Spoont
Michele R. Spoont
LMLaura A. Meis
Laura A. Meis
RORobert J. Orazem
Robert J. Orazem
MPMelissa A. Polusny
Melissa A. Polusny
Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT) are first-line treatments for posttraumatic stress disorder (PTSD) and have been disseminated throughout the U.S. Veterans Health Administration. Treatment non-completion is common and lessens clinical effectiveness; however, prior work has failed to identify factors consistently associated with non-completion. Semi-structured interviews were conducted with a national sample of veterans who recently completed (n = 60) or did not complete (n = 66) PE or CPT. Non-completer interviews focused on factors that contributed to veterans’ decisions to drop out and efforts undertaken to complete PE/CPT. Completer interviews focused on challenges faced in completing treatment and facilitators of completion. Transcripts were coded using a mixed deductive/inductive approach; constant comparison was used to identify differences between completers and non-completers. Completers and non-completers differed in the extent of treatment-specific therapist support received, therapists’ flexibility in treatment delivery, the type of encouragement offered by the care team and social supports, their interpretation of symptom worsening, the perceived impact of treatment on functioning, and the impact of stressors on their treatment engagement. Treatment-specific therapist support, more patient-centered and flexible treatment delivery, leveraging the full care team, and addressing functional concerns are potential targets for PE and CPT engagement interventions.

1 November 2021 in Contemporary Clinical Trials
Verified
Journal Article
Open access
APAlan L. Peterson
Alan L. Peterson
SYStacey Young-McCaughan
Stacey Young-McCaughan
JRJohn D. Roache
John D. Roache
JMJim Mintz
Jim Mintz
BLBrett T. Litz
Brett T. Litz
TKTerence M. Keane
Terence M. Keane
The STRONG STAR Consortium (South Texas Research Organizational Network Guiding Studies on Trauma and Resilience) and the Consortium to Alleviate PTSD are interdisciplinary and multi-institutional research consortia focused on the detection, diagnosis, prevention, and treatment of combat-related posttraumatic stress disorder (PTSD) and comorbid conditions in military personnel and veterans. This manuscript outlines the consortia's state-of-the-science collaborative research model and how this can be used as a roadmap for future trauma-related research. STRONG STAR was initially funded for 5 years in 2008 by the U.S. Department of Defense's (DoD) Psychological Health and Traumatic Brain Injury Research Program. Since the initial funding of STRONG STAR, almost 50 additional peer-reviewed STRONG STAR-affiliated projects have been funded through the DoD, the U.S. Department of Veterans Affairs (VA), the National Institutes of Health, and private organizations. In 2013, STRONG STAR investigators partnered with the VA's National Center for PTSD and were selected for joint DoD/VA funding to establish the Consortium to Alleviate PTSD. STRONG STAR and the Consortium to Alleviate PTSD have assembled a critical mass of investigators and institutions with the synergy required to make major scientific and public health advances in the prevention and treatment of combat PTSD and related conditions. This manuscript provides an overview of the establishment of these two research consortia, including their history, vision, mission, goals, and accomplishments. Comprehensive tables provide descriptions of over 70 projects supported by the consortia. Examples are provided of collaborations among over 50 worldwide academic research institutions and over 150 investigators.

29 July 2020 in Implementation Science
Verified
Journal Article
Open access
PDF file
EFEdna B. Foa
Edna B. Foa
CMCarmen P. McLean
Carmen P. McLean
LBLily A. Brown
Lily A. Brown
YZYinyin Zang
Yinyin Zang
DRDavid Rosenfield
David Rosenfield
FCfor the STRONG STAR Consortium
for the STRONG STAR Consortium
Background: Prolonged exposure therapy (PE) is an evidence-based treatment for posttraumatic stress disorder (PTSD) that is underutilized in the military health system. Standard workshop training in PE may not be sufficient to alter provider behavior, but post-workshop consultation requires significant resources. Therefore, it is important to determine the incremental utility of post-workshop consultation.Methods: This study used a hybrid type III randomized implementation trial at 3 US Army installations. Providers were randomized to receive a 4-day prolonged exposure workshop (Standard training condition,n= 60), or the prolonged exposure workshop followed by 6–8 months of post-workshop expert case consultation (Extended training condition,n= 43). The effects training condition were examined on provider attitudes (self-efficacy in delivering PE, expectations for patient improvement, and beliefs about PE), use of PE and PE components, and clinical outcomes of patients with PTSD (using the Clinician-Administered PTSD Scale (CAPS-5)).Results: Extended condition providers reported greater improvements in self-efficacy,b= .83, 95% CI [.38, 1.27],t(79) = 3.71,p= .001, andd= .63. A greater proportion of patients in the Extended condition (44%) than in the Standard condition (27%) received at least 1 PE session,b= .76,t(233) = 2.53,p= .012, and OR = 2.13. Extended condition providers used more PE components (M= .9/session) than did Standard condition providers (M= .5/session),b= .54, 95% CI [.15, .93],t(68) = 2.70,p= .007, andd= .68. Finally, decrease in patients’ PTSD symptoms was faster for patients of Extended condition providers than for patients of Standard condition providers,b= − 1.81, 95% CI [− 3.57, − .04],t(263) = − 2.02,p= .045, andd= .66, and their symptoms were lower at the second assessment,b= − 5.47, 95% CI [− 9.30, − 1.63],t(210) = − 2.81,p= .005, andd= .66.Conclusions: Post-workshop consultation improved self-efficacy for delivering PE, greater use of PE, faster PTSD reduction, and lower PTSD severity at the second assessment. To our knowledge, this is the first demonstration that post-workshop case consultation for PE improves patient outcomes.Trial registration: Clinicaltrials.gov,NCT02982538. Registered December 5, 2016; retrospectively registered

26 January 2022 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
EFEdna B. Foa
Edna B. Foa
HSHelen Blair Simpson
Helen Blair Simpson
TGThea Gallagher
Thea Gallagher
MWMichael G. Wheaton
Michael G. Wheaton
MGMarina Gershkovich
Marina Gershkovich
DRDavid Rosenfield
David Rosenfield
Obsessive-compulsive disorder (OCD) is a debilitating illness characterized by obsessions and compulsions. Effective first-line treatments include serotonin reuptake inhibitors (SRIs) and exposure/response prevention (EX/RP).1,2 SRIs are the only medications approved by the US Food and Drug Administration for OCD. However, although many patients respond to SRIs,3 most continue to exhibit clinically significant symptoms affecting their quality of life.3-7 For these patients, treatment guidelines recommend changing to another SRI and augmenting either with another medication or EX/RP.1,2 Augmenting SRIs with EX/RP has been found to be superior to adding risperidone7 or stress management therapy.6